Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars
Launched by CAIRO UNIVERSITY · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a new type of dental material called bioceramic putty MTA compared to a traditional material known as MTA in a treatment called pulpotomy for young permanent molars. A pulpotomy is a procedure used to treat teeth that have deep cavities but are still growing. The main goal of the study is to see if the new bioceramic material leads to better healing and success rates than the traditional MTA when treating these teeth.
To participate in this trial, children aged 6 to 8 years with specific dental conditions will be eligible. They should have permanent molars that are still developing and have deep cavities that need treatment, but they must not show any signs of serious infection or damage. This means their teeth should not be painful or have swelling, and there should be no concerning findings on dental X-rays. It's important to note that children with other health issues or those who have had previous dental work on the same teeth will not be included. If eligible, participants can expect to receive either the new bioceramic putty or the traditional material during their dental treatment, and their progress will be monitored over time to determine which material works better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged from 6-8 years of both sexes have immature permanent molars
- • with deep carious lesions indicated for pulpotomy.
- • Restorable young permanent molars with no clinical symptoms of irreversible pulpitis.
- • Permanent molars without any clinical sign of pulp necrosis including swelling, fistula, pain on percussion, and pathologic tooth mobility.
- • Permanent molars without any adverse radiographic findings including thickening of the periodontal ligament space, radiolucency at the interradicular or periapical regions
- • permanent molars without internal and external root resorption, or calcification in pulp tissue.
- Exclusion Criteria:
- • Medically compromised patients who have systemic disease.
- • Uncooperative patients who refuse treatment.
- • Permanent molars that were previously restored.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported